Large-scale genome-wide association studies have identified multiple single-nucleotide polymorphisms associated with risk of prostate cancer. Many of these genetic variants are presumed to be regulatory in nature; however, follow-up expression quantitative trait loci (eQTL) association studies have to-date been restricted largely to -acting associations due to study limitations. While -eQTL scans suffer from high testing dimensionality, recent evidence indicates most -eQTL associations are mediated by -regulated genes, such as transcription factors. Leveraging a data-driven gene co-expression network, we conducted a comprehensive -mediator analysis using RNA-Seq data from 471 normal prostate tissue samples to identify downstream regulatory associations of previously identified prostate cancer risk variants. We discovered multiple -eQTL associations that were significantly mediated by -regulated transcripts, four of which involved risk locus 17q12, proximal transcription factor , and target -genes with known HNF response elements (, , , ). We additionally identified evidence of -acting down-regulation of via rs10993994 corresponding to reduced co-expression of . The majority of these -mediator relationships demonstrated -eQTL replicability in 87 prostate tissue samples from the Gene-Tissue Expression Project. These findings provide further biological context to known risk loci and outline new hypotheses for investigation into the etiology of prostate cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689655PMC
http://dx.doi.org/10.18632/oncotarget.20717DOI Listing

Publication Analysis

Top Keywords

prostate cancer
16
prostate tissue
12
normal prostate
8
downstream regulatory
8
regulatory associations
8
association studies
8
-eqtl associations
8
associations mediated
8
mediated -regulated
8
tissue samples
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!